These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 22406115)

  • 21. Liver X receptor is a regulator of orphan nuclear receptor NOR-1 gene transcription in adipocytes.
    Kumar N; Wang H; Liu D; Collins S
    Int J Obes (Lond); 2009 May; 33(5):519-24. PubMed ID: 19238156
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A reversed sulfonamide series of selective RORc inverse agonists.
    van Niel MB; Fauber BP; Cartwright M; Gaines S; Killen JC; René O; Ward SI; de Leon Boenig G; Deng Y; Eidenschenk C; Everett C; Gancia E; Ganguli A; Gobbi A; Hawkins J; Johnson AR; Kiefer JR; La H; Lockey P; Norman M; Ouyang W; Qin A; Wakes N; Waszkowycz B; Wong H
    Bioorg Med Chem Lett; 2014 Dec; 24(24):5769-5776. PubMed ID: 25453817
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Separate and overlapping metabolic functions of LXRalpha and LXRbeta in C57Bl/6 female mice.
    Korach-André M; Parini P; Larsson L; Arner A; Steffensen KR; Gustafsson JA
    Am J Physiol Endocrinol Metab; 2010 Feb; 298(2):E167-78. PubMed ID: 19690071
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of novel liver X receptor activators by structure-based modeling.
    von Grafenstein S; Mihaly-Bison J; Wolber G; Bochkov VN; Liedl KR; Schuster D
    J Chem Inf Model; 2012 May; 52(5):1391-400. PubMed ID: 22489742
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and activity evaluation of a series of cholanamides as modulators of the liver X receptors.
    Martínez MD; Ghini AA; Dansey MV; Veleiro AS; Pecci A; Alvarez LD; Burton G
    Bioorg Med Chem; 2018 Mar; 26(5):1092-1101. PubMed ID: 29428525
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discovery of tertiary sulfonamides as potent liver X receptor antagonists.
    Zuercher WJ; Buckholz RG; Campobasso N; Collins JL; Galardi CM; Gampe RT; Hyatt SM; Merrihew SL; Moore JT; Oplinger JA; Reid PR; Spearing PK; Stanley TB; Stewart EL; Willson TM
    J Med Chem; 2010 Apr; 53(8):3412-6. PubMed ID: 20345102
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identify liver X receptor β modulator building blocks by developing a fluorescence polarization-based competition assay.
    Zhang Z; Chen H; Chen Z; Ding P; Ju Y; Gu Q; Xu J; Zhou H
    Eur J Med Chem; 2019 Sep; 178():458-467. PubMed ID: 31202993
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discovery and optimization of a series of liver X receptor antagonists.
    Jiao X; Kopecky DJ; Fisher B; Piper DE; Labelle M; McKendry S; Harrison M; Jones S; Jaen J; Shiau AK; Escaron P; Danao J; Chai A; Coward P; Kayser F
    Bioorg Med Chem Lett; 2012 Sep; 22(18):5966-70. PubMed ID: 22901900
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Simultaneous activation of the liver X receptors (LXRα and LXRβ) drives murine collagen-induced arthritis disease pathology.
    Asquith DL; Miller AM; Reilly J; Kerr S; Welsh P; Sattar N; McInnes IB
    Ann Rheum Dis; 2011 Dec; 70(12):2225-8. PubMed ID: 21859686
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design, synthesis, and biological evaluation of novel transrepression-selective liver X receptor (LXR) ligands with 5,11-dihydro-5-methyl-11-methylene-6H-dibenz[b,e]azepin-6-one skeleton.
    Aoyama A; Endo-Umeda K; Kishida K; Ohgane K; Noguchi-Yachide T; Aoyama H; Ishikawa M; Miyachi H; Makishima M; Hashimoto Y
    J Med Chem; 2012 Sep; 55(17):7360-77. PubMed ID: 22873709
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular basis for repression of liver X receptor-mediated gene transcription by receptor-interacting protein 140.
    Jakobsson T; Osman W; Gustafsson JA; Zilliacus J; Wärnmark A
    Biochem J; 2007 Jul; 405(1):31-9. PubMed ID: 17391100
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Advances in our structural understanding of orphan nuclear receptors.
    Gallastegui N; Mackinnon JA; Fletterick RJ; Estébanez-Perpiñá E
    Trends Biochem Sci; 2015 Jan; 40(1):25-35. PubMed ID: 25499868
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identfication of Potent LXRβ-Selective Agonists without LXRα Activation by In Silico Approaches.
    Chen M; Yang F; Kang J; Gan H; Yang X; Lai X; Gao Y
    Molecules; 2018 Jun; 23(6):. PubMed ID: 29867043
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and SAR of potent LXR agonists containing an indole pharmacophore.
    Washburn DG; Hoang TH; Campobasso N; Smallwood A; Parks DJ; Webb CL; Frank KA; Nord M; Duraiswami C; Evans C; Jaye M; Thompson SK
    Bioorg Med Chem Lett; 2009 Feb; 19(4):1097-100. PubMed ID: 19167885
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Liver X receptors interact with corepressors to regulate gene expression.
    Hu X; Li S; Wu J; Xia C; Lala DS
    Mol Endocrinol; 2003 Jun; 17(6):1019-26. PubMed ID: 12663743
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HDAC3 interacts with sumoylated C/EBPα to negatively regulate the LXRα expression in rat hepatocytes.
    Ren J; Li D; Li Y; Lan X; Zheng J; Wang X; Ma J; Lu S
    Mol Cell Endocrinol; 2013 Jul; 374(1-2):35-45. PubMed ID: 23639777
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The N-terminal nuclear localization sequences of liver X receptors alpha and beta bind to importin alpha and are essential for both nuclear import and transactivating functions.
    Miller A; Crumbley C; Prüfer K
    Int J Biochem Cell Biol; 2009 Apr; 41(4):834-43. PubMed ID: 18773967
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pyrrole derivatives as potent inhibitors of lymphocyte-specific kinase: Structure, synthesis, and SAR.
    Takayama T; Umemiya H; Amada H; Yabuuchi T; Shiozawa F; Katakai H; Takaoka A; Yamaguchi A; Endo M; Sato M
    Bioorg Med Chem Lett; 2010 Jan; 20(1):108-11. PubMed ID: 19945869
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 2-Aryl-N-acyl indole derivatives as liver X receptor (LXR) agonists.
    Kher S; Lake K; Sircar I; Pannala M; Bakir F; Zapf J; Xu K; Zhang SH; Liu J; Morera L; Sakurai N; Jack R; Cheng JF
    Bioorg Med Chem Lett; 2007 Aug; 17(16):4442-6. PubMed ID: 17587573
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Liver X receptor α and farnesoid X receptor are major transcriptional regulators of OATP1B1.
    Meyer Zu Schwabedissen HE; Böttcher K; Chaudhry A; Kroemer HK; Schuetz EG; Kim RB
    Hepatology; 2010 Nov; 52(5):1797-807. PubMed ID: 20827719
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.